Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Maintenance Organizations | 8 | 2007 | 678 | 0.390 |
Why?
|
| Treatment Refusal | 5 | 2008 | 420 | 0.270 |
Why?
|
| Patient Compliance | 7 | 2009 | 2744 | 0.250 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2993 | 0.230 |
Why?
|
| Drug Utilization | 7 | 2008 | 1236 | 0.230 |
Why?
|
| Benzodiazepines | 5 | 2007 | 1085 | 0.190 |
Why?
|
| RNA Polymerase II | 1 | 2003 | 538 | 0.180 |
Why?
|
| Drug Therapy | 3 | 2008 | 517 | 0.170 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2007 | 391 | 0.160 |
Why?
|
| Drug Prescriptions | 5 | 2008 | 1687 | 0.160 |
Why?
|
| Models, Statistical | 2 | 2008 | 5064 | 0.150 |
Why?
|
| Research Design | 3 | 2008 | 5902 | 0.150 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2003 | 857 | 0.150 |
Why?
|
| Drug Costs | 4 | 2008 | 1170 | 0.130 |
Why?
|
| Legislation, Drug | 2 | 2007 | 232 | 0.120 |
Why?
|
| Medicare Part D | 2 | 2008 | 309 | 0.120 |
Why?
|
| Anti-Anxiety Agents | 2 | 2007 | 393 | 0.120 |
Why?
|
| Medical Indigency | 3 | 2008 | 66 | 0.120 |
Why?
|
| Prescriptions | 2 | 2008 | 347 | 0.120 |
Why?
|
| Antidepressive Agents | 4 | 2007 | 2827 | 0.120 |
Why?
|
| Postnatal Care | 3 | 2004 | 230 | 0.120 |
Why?
|
| Health Policy | 5 | 2008 | 2649 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 5947 | 0.100 |
Why?
|
| Diabetes Mellitus | 6 | 2009 | 5463 | 0.100 |
Why?
|
| Hypoglycemic Agents | 5 | 2009 | 2775 | 0.090 |
Why?
|
| Insurance, Pharmaceutical Services | 3 | 2007 | 348 | 0.090 |
Why?
|
| Medicaid | 6 | 2008 | 2649 | 0.090 |
Why?
|
| Meningococcal Vaccines | 1 | 2008 | 100 | 0.080 |
Why?
|
| Hip Fractures | 2 | 2007 | 877 | 0.080 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2008 | 134 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2008 | 635 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2008 | 6495 | 0.070 |
Why?
|
| Marketing | 1 | 2008 | 239 | 0.070 |
Why?
|
| Length of Stay | 3 | 2004 | 6267 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2006 | 171 | 0.070 |
Why?
|
| Depressive Disorder | 3 | 2007 | 3804 | 0.070 |
Why?
|
| Jaundice, Neonatal | 1 | 2004 | 61 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2006 | 333 | 0.060 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2008 | 498 | 0.060 |
Why?
|
| Pirenzepine | 1 | 2003 | 117 | 0.060 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2003 | 41 | 0.060 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2003 | 43 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2003 | 71 | 0.060 |
Why?
|
| Receptor, Notch1 | 1 | 2006 | 519 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2003 | 275 | 0.060 |
Why?
|
| Antipsychotic Agents | 2 | 2008 | 3062 | 0.060 |
Why?
|
| Patient Discharge | 3 | 2003 | 3030 | 0.060 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 259 | 0.060 |
Why?
|
| Haloperidol | 1 | 2003 | 383 | 0.060 |
Why?
|
| Histidine | 1 | 2003 | 329 | 0.050 |
Why?
|
| Medicare | 3 | 2008 | 5791 | 0.050 |
Why?
|
| Fee-for-Service Plans | 1 | 2006 | 652 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 1199 | 0.050 |
Why?
|
| Infant Care | 1 | 2002 | 189 | 0.050 |
Why?
|
| Disabled Persons | 2 | 2007 | 1149 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 1201 | 0.050 |
Why?
|
| Alanine | 1 | 2003 | 586 | 0.050 |
Why?
|
| Warfarin | 1 | 2008 | 1476 | 0.050 |
Why?
|
| Massachusetts | 7 | 2007 | 8743 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2008 | 12480 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2008 | 11090 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 672 | 0.050 |
Why?
|
| Serine | 1 | 2003 | 827 | 0.040 |
Why?
|
| New York | 3 | 2007 | 860 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2004 | 825 | 0.040 |
Why?
|
| Breast Feeding | 2 | 2004 | 1290 | 0.040 |
Why?
|
| Aftercare | 1 | 2003 | 718 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2003 | 1155 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2004 | 1047 | 0.040 |
Why?
|
| Plasmids | 1 | 2003 | 2459 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2006 | 2480 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2003 | 3213 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 1839 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3964 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 2330 | 0.030 |
Why?
|
| New Jersey | 2 | 2007 | 288 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2003 | 5379 | 0.030 |
Why?
|
| Disease Management | 1 | 2006 | 2523 | 0.030 |
Why?
|
| Humans | 33 | 2009 | 715777 | 0.030 |
Why?
|
| Health Expenditures | 2 | 2008 | 2270 | 0.030 |
Why?
|
| Transfection | 1 | 2003 | 6089 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 1410 | 0.030 |
Why?
|
| Male | 24 | 2009 | 350324 | 0.030 |
Why?
|
| Aged | 16 | 2009 | 162448 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6214 | 0.030 |
Why?
|
| Female | 25 | 2009 | 377204 | 0.030 |
Why?
|
| Health Care Surveys | 3 | 2007 | 2512 | 0.030 |
Why?
|
| Middle Aged | 18 | 2009 | 214639 | 0.030 |
Why?
|
| Socioeconomic Factors | 4 | 2008 | 7757 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2008 | 4375 | 0.030 |
Why?
|
| State Health Plans | 2 | 2006 | 217 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2003 | 3516 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2004 | 1863 | 0.030 |
Why?
|
| African Americans | 1 | 2007 | 5003 | 0.030 |
Why?
|
| Anxiety | 1 | 2006 | 3916 | 0.030 |
Why?
|
| Pain | 1 | 2006 | 4697 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2003 | 8658 | 0.030 |
Why?
|
| Demography | 2 | 2006 | 1625 | 0.030 |
Why?
|
| Peptides | 1 | 2003 | 4384 | 0.020 |
Why?
|
| Longitudinal Studies | 4 | 2009 | 13643 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2006 | 3409 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4282 | 0.020 |
Why?
|
| Adult | 15 | 2009 | 212266 | 0.020 |
Why?
|
| United States | 9 | 2008 | 67905 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2009 | 3956 | 0.020 |
Why?
|
| Protein Binding | 1 | 2003 | 9559 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 6702 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7885 | 0.020 |
Why?
|
| New Hampshire | 1 | 2008 | 172 | 0.020 |
Why?
|
| Maine | 1 | 2008 | 141 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 480 | 0.020 |
Why?
|
| Diabetes Complications | 2 | 2006 | 1397 | 0.020 |
Why?
|
| Hydrocodone | 1 | 2006 | 47 | 0.020 |
Why?
|
| Cohort Studies | 5 | 2008 | 40029 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2004 | 4454 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2003 | 5054 | 0.020 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2006 | 102 | 0.020 |
Why?
|
| Anti-Ulcer Agents | 1 | 2006 | 116 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2008 | 313 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2004 | 5031 | 0.020 |
Why?
|
| Oxycodone | 1 | 2006 | 140 | 0.020 |
Why?
|
| Aged, 80 and over | 5 | 2008 | 58323 | 0.020 |
Why?
|
| Self Administration | 1 | 2006 | 385 | 0.020 |
Why?
|
| Methadone | 1 | 2006 | 292 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 2004 | 116 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2004 | 11953 | 0.020 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2004 | 101 | 0.020 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 151 | 0.020 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2006 | 254 | 0.020 |
Why?
|
| Half-Life | 1 | 2004 | 674 | 0.010 |
Why?
|
| Age Factors | 3 | 2007 | 18784 | 0.010 |
Why?
|
| Insurance Claim Review | 1 | 2008 | 750 | 0.010 |
Why?
|
| Health Plan Implementation | 1 | 2006 | 357 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 11201 | 0.010 |
Why?
|
| Morphine | 1 | 2006 | 637 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2009 | 72443 | 0.010 |
Why?
|
| Logistic Models | 2 | 2008 | 13618 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2007 | 935 | 0.010 |
Why?
|
| Phototherapy | 1 | 2004 | 338 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2003 | 1053 | 0.010 |
Why?
|
| Comorbidity | 2 | 2007 | 10435 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2006 | 2371 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1778 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2003 | 327 | 0.010 |
Why?
|
| Cost Control | 1 | 2002 | 626 | 0.010 |
Why?
|
| Prevalence | 2 | 2007 | 14911 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2006 | 790 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 849 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 1312 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2004 | 24798 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1821 | 0.010 |
Why?
|
| Psychometrics | 1 | 2008 | 2971 | 0.010 |
Why?
|
| Milk, Human | 1 | 2003 | 477 | 0.010 |
Why?
|
| Data Collection | 1 | 2008 | 3317 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 29291 | 0.010 |
Why?
|
| Adolescent | 4 | 2008 | 85155 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4893 | 0.010 |
Why?
|
| Health Surveys | 1 | 2008 | 4036 | 0.010 |
Why?
|
| Maternal Health Services | 1 | 2003 | 438 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2006 | 2539 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 4688 | 0.010 |
Why?
|
| Home Care Services | 1 | 2002 | 593 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6641 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 2361 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2729 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 1727 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2004 | 1356 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 23438 | 0.010 |
Why?
|
| Psychiatry | 1 | 2007 | 1623 | 0.010 |
Why?
|
| Animals | 2 | 2006 | 169420 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 3580 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2008 | 3318 | 0.010 |
Why?
|
| Social Class | 1 | 2003 | 1983 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12456 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2003 | 6183 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 7140 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2003 | 2003 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 4378 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2003 | 2650 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 39300 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 4262 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 6651 | 0.010 |
Why?
|
| Young Adult | 2 | 2008 | 56226 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 9030 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3149 | 0.010 |
Why?
|
| Boston | 1 | 2004 | 9377 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 21797 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2007 | 4522 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2003 | 2755 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 15059 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 19537 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2007 | 5038 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10620 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 11945 | 0.010 |
Why?
|
| Health Status | 1 | 2003 | 4001 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 16736 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2007 | 12535 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2002 | 2980 | 0.010 |
Why?
|
| Incidence | 1 | 2007 | 20731 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 16311 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 22665 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18199 | 0.000 |
Why?
|
| Hospitalization | 1 | 2002 | 9745 | 0.000 |
Why?
|
| Emergency Service, Hospital | 1 | 2002 | 7499 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2006 | 23729 | 0.000 |
Why?
|
| Child | 1 | 2008 | 74468 | 0.000 |
Why?
|
| Mice | 1 | 2006 | 80375 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 62004 | 0.000 |
Why?
|
| Risk Factors | 1 | 2003 | 70866 | 0.000 |
Why?
|
| Neoplasms | 1 | 2003 | 20528 | 0.000 |
Why?
|
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_